(1) Improvement of severity of DR following treatment with anti-VEGF with aflibercept associating with more improvement at year 1 and 2 even in the absence of re-perfusions might have played a role [17, 18], as less severe retinopathy is associated with lower vO2S and higher AVdO2S [1, 2]. This evidence concerns the gene VEGFA and retinal disorder.